The GUF1 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from Jurkat human T lymphocytes. These cells harbor a disrupted GUF1 gene, resulting in a loss-of-function model for the mitochondrial translation elongation factor GUF1. This polyclonal pool offers a genetically diverse resource for studying GUF1-dependent processes without clonal selection, enabling robust and reproducible investigation of mitochondrial translation defects in an immune cell context.
Jurkat cells are an immortalized T lymphocyte line widely used in immunological research, originally established from a patient with acute T cell leukemia. Their well-characterized T cell receptor signaling and apoptosis pathways provide a relevant platform for examining mitochondrial?Cimmune interplay. The Jurkat background is particularly suited for studies of mitochondrial biology, as T cells undergo metabolic reprogramming upon activation, transitioning between oxidative phosphorylation and glycolysis.
GUF1, as mitochondrial elongation factor G, promotes ribosomal translocation on mitochondrial mRNAs and cooperates with mtRRF for ribosome recycling, enabling efficient translation of mtDNA-encoded respiratory chain subunits. Its expression is regulated by upstream factors including PGC-1??, NRF1, TFAM, and mTOR. Downstream, GUF1 activity is critical for synthesis of MT-CO1, MT-CO2, and MT-ND1, which are essential components of OXPHOS complexes I and IV. GUF1 functionally interacts with mitochondrial ribosome subunits, mtEFTu, and MRPL12, integrating into the mitochondrial translation machinery. Disruption of GUF1 therefore impairs mitochondrial protein synthesis, compromising ATP production and OXPHOS complex assembly.
In Jurkat T cells, mitochondrial translation is intimately linked to cellular activation, proliferation, and metabolic adaptation. The GUF1 knockout polyclonal model allows dissection of how mitochondrial proteostasis defects affect T cell function and viability. Given that Jurkat cells share features with leukemic cells, they often possess altered metabolic dependencies, making them valuable for exploring mitochondrial vulnerabilities in cancer. GUF1 loss in this context can reveal the reliance of T cell metabolism on mitochondrial translation, with potential implications for understanding mitochondrial dysfunction in immunological disorders and tumor biology.
Applications of these cells encompass genetic screening for mitochondrial translation deficiencies, functional analyses of T cell metabolism, and pharmacological testing of agents targeting mitochondrial function. Compatible assays include Western blotting for mtDNA-encoded proteins (e.g., MT-CO1), RT-qPCR of mitochondrial transcripts, Seahorse respirometry, flow cytometric detection of mitochondrial superoxide, MTT assays, and in organello translation measurements. This model thus supports comprehensive investigation of the mitochondrial translation pathway in human T lymphocytes. For additional information, reach out to Ascent Research.
